Literature DB >> 35262529

Brief Report: Heterogeneous Preferences for Care Engagement Among People With HIV Experiencing Homelessness or Unstable Housing During the COVID-19 Pandemic.

Elizabeth Imbert1, Matthew D Hickey1, Jan Bing Del Rosario1, Madellena Conte2, Andrew D Kerkhoff1, Angelo Clemenzi-Allen1,3, Elise D Riley1, Diane V Havlir1, Monica Gandhi1.   

Abstract

BACKGROUND/
SETTING: In San Francisco, HIV viral suppression is 71% among housed individuals but only 20% among unhoused individuals. We conducted a discrete choice experiment at a San Francisco public HIV clinic to evaluate care preferences among people living with HIV (PLH) experiencing homelessness/unstable housing during the COVID-19 pandemic.
METHODS: From July to November 2020, we conducted a discrete choice experiment among PLH experiencing homelessness/unstable housing who accessed care through (1) an incentivized, drop-in program (POP-UP) or (2) traditional primary care. We investigated 5 program features: single provider vs team of providers; visit incentives ($0, $10, and $20); location (current site vs current + additional site); drop-in vs scheduled visits; in-person only vs optional telehealth visits; and navigator assistance. We estimated relative preferences using mixed-effects logistic regression and conducted latent class analysis to evaluate preference heterogeneity.
RESULTS: We enrolled 115 PLH experiencing homelessness/unstable housing, 40% of whom lived outdoors. The strongest preferences were for the same provider (β = 0.94, 95% CI: 0.48 to 1.41), visit incentives (β = 0.56 per $5; 95% CI: 0.47 to 0.66), and drop-in visits (β = 0.47, 95% CI: 0.12 to 0.82). Telehealth was not preferred. Latent class analysis revealed 2 distinct groups: 78 (68%) preferred a flexible care model, whereas 37 (32%) preferred a single provider.
CONCLUSIONS: We identified heterogeneous care preferences among PLH experiencing homelessness/unstable housing during the COVID-19 pandemic, with two-thirds preferring greater flexibility and one-third preferring provider continuity. Telehealth was not preferred, even with navigator facilitation. Including patient choice in service delivery design can improve care engagement, particularly for marginalized populations, and is an essential tool for ending the HIV epidemic.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35262529      PMCID: PMC9203876          DOI: 10.1097/QAI.0000000000002929

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  28 in total

1.  Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.

Authors:  John F P Bridges; A Brett Hauber; Deborah Marshall; Andrew Lloyd; Lisa A Prosser; Dean A Regier; F Reed Johnson; Josephine Mauskopf
Journal:  Value Health       Date:  2011-04-22       Impact factor: 5.725

2.  No Digital Divide? Technology Use among Homeless Adults.

Authors:  Harmony Rhoades; Suzanne Wenzel; Eric Rice; Hailey Winetrobe; Benjamin Henwood
Journal:  J Soc Distress Homeless       Date:  2017-03-22

3.  Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force.

Authors:  F Reed Johnson; Emily Lancsar; Deborah Marshall; Vikram Kilambi; Axel Mühlbacher; Dean A Regier; Brian W Bresnahan; Barbara Kanninen; John F P Bridges
Journal:  Value Health       Date:  2013 Jan-Feb       Impact factor: 5.725

4.  Is HIV patient navigation associated with HIV care continuum outcomes?

Authors:  Yuko Mizuno; Darrel H Higa; Carolyn A Leighton; Katherine B Roland; Julia B Deluca; Linda J Koenig
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

5.  Pragmatic randomized trial of a pre-visit intervention to improve the quality of telemedicine visits for vulnerable patients living with HIV.

Authors:  Matthew D Hickey; Francesco Sergi; Kevin Zhang; Matthew A Spinelli; Douglas Black; Cyril Sola; Vanessa Blaz; Janet Q Nguyen; Jon Oskarsson; Monica Gandhi; Diane V Havlir
Journal:  J Telemed Telecare       Date:  2020-12-20       Impact factor: 6.344

Review 6.  Improving Health Care Management in Primary Care for Homeless People: A Literature Review.

Authors:  Maeva Jego; Julien Abcaya; Diana-Elena Ștefan; Céline Calvet-Montredon; Stéphanie Gentile
Journal:  Int J Environ Res Public Health       Date:  2018-02-10       Impact factor: 3.390

7.  Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program.

Authors:  K Michelle Peavy; James Darnton; Paul Grekin; Monica Russo; Caleb J Banta Green; Joseph O Merrill; Charissa Fotinos; Steve Woolworth; Sean Soth; Judith I Tsui
Journal:  AIDS Behav       Date:  2020-09

8.  COVID-19 and the US response: accelerating health inequities.

Authors:  Nneoma E Okonkwo; Ugochi T Aguwa; Minyoung Jang; Iman A Barré; Kathleen R Page; Patrick S Sullivan; Chris Beyrer; Stefan Baral
Journal:  BMJ Evid Based Med       Date:  2020-06-03

9.  Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing.

Authors:  Elizabeth Imbert; Matthew D Hickey; Angelo Clemenzi-Allen; Elizabeth Lynch; John Friend; Jackelyn Kelley; Madellena Conte; Doyel Das; Jan Bing Del Rosario; Erin Collins; Jon Oskarsson; Mary Lawrence Hicks; Elise D Riley; Diane V Havlir; Monica Gandhi
Journal:  AIDS       Date:  2021-07-01       Impact factor: 4.632

10.  Understanding preferences for HIV care and treatment in Zambia: Evidence from a discrete choice experiment among patients who have been lost to follow-up.

Authors:  Arianna Zanolini; Kombatende Sikombe; Izukanji Sikazwe; Ingrid Eshun-Wilson; Paul Somwe; Carolyn Bolton Moore; Stephanie M Topp; Nancy Czaicki; Laura K Beres; Chanda P Mwamba; Nancy Padian; Charles B Holmes; Elvin H Geng
Journal:  PLoS Med       Date:  2018-08-13       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.